Free Trial

Zacks Research's Rating of Biocorrx on 9/2/2025

On September 2, 2025, Zacks Research updated its outlook on Biocorrx (OTCMKTS:BICX) with the action "Upgrade", setting a "Hold" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Zacks Research

DateCompanyAction
5/1/2026
XP Inc. stock logo
XP
XP
Downgrade
5/1/2026
Warner Bros. Discovery, Inc. stock logo
WBD
Warner Bros. Discovery
Downgrade
5/1/2026
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
Downgrade
5/1/2026
Seagate Technology Holdings PLC stock logo
STX
Seagate Technology
Upgrade
5/1/2026
Sterling Infrastructure, Inc. stock logo
STRL
Sterling Infrastructure
Downgrade
5/1/2026
Ring Energy, Inc. stock logo
REI
Ring Energy
Upgrade
More Ratings From Zacks Research